Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04131894Phase 4Completed
Phase 4, randomised, single-blind trial (3 arms), sponsored by Bahçeşehir University. Primary endpoints: Histopathological Evaluation at 3 months, Immunohistochemical Evaluation at 3 months and 1 more. Started Dec 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04131894.